Immunic Inc. buy Roth Capital
Start price
07.11.25
/
50%
€0.60
Target price
07.11.26
€2.60
Performance (%)
67.22%
Price
10.04.26
€1.00
Summary
This prediction is currently active. The BUY prediction by Roth_Capital for Immunic Inc. has seen massive gains of 67.22%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Roth_Capital at any time. Roth_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunic Inc. | 0.806% | 0.806% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Roth_Capital for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat